Filing Details

Accession Number:
0001415889-22-005627
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-24 19:11:35
Reporting Period:
2022-05-20
Accepted Time:
2022-05-24 19:11:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1583107 Theravance Biopharma Inc. TBPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1898490 Rhonda Farnum C/O Theravance Biopharma Us, Inc.
901 Gateway Blvd
South San Francisco CA 94080
Svp, Comm & Medical Affairs No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2022-05-20 2,200 $8.74 331,071 No 4 F Direct
Ordinary Shares Disposition 2022-05-23 1,081 $8.93 329,990 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
  2. This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 5/17/21.